Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contraceptive efficacy, safety and tolerability of Levonorgestrel Vaginal Delivery System over 13 cycles
2022-502023-21-00Phase 3Completed
- Sponsor
- Chemo
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 3, open-label, single-arm trial of avatrombopag in contraception, sponsored by Chemo. Primary endpoint: Overall Pearl Index in non-breastfeeding women aged 18 to 35 years. Started Jul 2023; status: completed.
02
Drugs
avatrombopag
03
Conditions
contraception
Beyond the preview
Go deeper on 2022-502023-21-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-502023-21-00.